Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Cleveland OH, Columbus OH, Fairfax VA,
Sponsor: Synthekine

Sex: All

Age: 18+

Code: NCT05098132

Phase1, Phase2, Recruiting

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

for
AAA - Abdominal Aortic Aneurysm
Location: Cleveland OH, Charleston WV, Buffalo NY, Bay City MI,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT06218875

Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

for
Non-muscle-invasive Bladder Cancer
Location: Cleveland OH, West Haven CT, St Louis MO,
Sponsor: White River Junction Veterans Affairs Medical Center

Sex: All

Age: 18+

Code: NCT05796375

Phase2, Recruiting
New

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

for
Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer,
Location: Cleveland OH, St Louis MO
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 21+

Code: NCT07824583

Recruiting

Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery

for
Total Knee Arthroplasty
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 0+

Code: NCT06946368

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Celveland OH, Sewickley PA, Monroeville PA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase3, Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Baltimore MD,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase1, Phase2, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Cleveland OH, Buffalo NY, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase3, Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Cleveland OH, Pittsburgh PA, Dublin OH, Columbus OH,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Cleveland OH, Columbus OH, Toledo OH, Detroit MI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Cleveland OH, Morgantown WV, Indianapolis IN, Durham NC,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Cleveland OH, London, Toronto, Indianapolis IN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase2, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Cleveland OH, Cincinnati OH, Indianapolis IN,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase2, Phase3, Recruiting

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

for
Sickle Cell Disease
Location: Cleveland OH
Sponsor: University of California, Irvine

Sex: All

Age: 14+

Code: NCT06853158

Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

for
Recurrent Pericarditis, Heart Diseases, Pericarditis
Location: Cleveland OH, Cincinnati OH, Charlottesville VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07288216

Phase2, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Cleveland OH, Detroit MI, Toronto, Grand Rapids MI,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase1, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Cleveland OH, Farmington MI, Dayton OH, Cincinnati OH,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase3, Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

for
Interstitial Lung Disease
Location: Cleveland OH, Chicago IL, Richmond VA, New York NY,
Sponsor: aTyr Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05892614

Phase2, Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

for
B-cell Mediated Autoimmune Disorders
Location: Cleveland OH, Columbus OH, Ann Arbor MI, Rochester NY,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06680037

Phase1, Recruiting